Last reviewed · How we verify
Geriavit (homonicotinic acid)
Geriavit (generic name: homonicotinic acid) is a homonicotinic acid drug. It is currently in unknown development.
Geriavit works by binding to the hydroxycarboxylic acid receptor 2, which is involved in various cellular processes.
Geriavit, a homonicotinic acid, is a small molecule targeting the hydroxycarboxylic acid receptor 2. Its mechanism of action is not well-documented, and it is not FDA-approved for any indications. As a result, there is limited information available on its commercial status, safety considerations, or pharmacokinetic properties. Further research is needed to fully understand Geriavit's potential therapeutic applications and risks. Currently, it is unclear whether Geriavit is patented or available as a generic medication.
At a glance
| Generic name | homonicotinic acid |
|---|---|
| Drug class | homonicotinic acid |
| Target | Hydroxycarboxylic acid receptor 2 |
| Therapeutic area | Other |
| Phase | unknown |
Mechanism of action
Imagine your cells have locks on them, and Geriavit has a key that fits into one of those locks. When it binds, it can influence how the cell behaves, potentially leading to changes in how the body responds to certain conditions. However, the exact details of how this works are still being studied.
Approved indications
Common side effects
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Geriavit CI brief — competitive landscape report
- Geriavit updates RSS · CI watch RSS
- portfolio CI
Frequently asked questions about Geriavit
What is Geriavit?
How does Geriavit work?
What is the generic name of Geriavit?
What drug class is Geriavit in?
What development phase is Geriavit in?
What does Geriavit target?
Related
- Drug class: All homonicotinic acid drugs
- Target: All drugs targeting Hydroxycarboxylic acid receptor 2
- Manufacturer: — full pipeline
- Therapeutic area: All drugs in Other
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing